tirzepatide approved in canada Health has the first sleep apnea drug for adults with obesity Health Canada approves Mounjaro (tirzepatide)
Description
2017;5(1):e000341
External resources New England Journal of Medicine: Retatrutide Phase 2 Trial for Obesity PMC: Comparative Efficacy of Tirzepatide vs Retatrutide Network Meta-Analysis Nature Medicine: Retatrutide for Metabolic Dysfunction-Associated Steatotic Liver Disease U.S
It is a dual agonist that activates both the GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors simultaneously
The average reduction in waist circumference was 18.4 cm in the tirzepatide group compared with 13.0 cm in the semaglutide group
Talk with your provider about your injection strategy. How Much Does Tirzepatide Cost
Your provider alters doses when needed
